Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

19
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
19
T Cell Types and Functions01:24

T Cell Types and Functions

3.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.1K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

63.9K
Overview
63.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The T-cell receptor in multiple sclerosis.

Annals of the New York Academy of Sciences·1995
Same author

A workshop on thymus, clonal deletion and suppressor systems in demyelinating disease. 20-24 March 1991, Eldorado Hotel, Sante Fe, NM, USA.

Journal of neuroimmunology·1992
Same author

Nucleotide sequence analysis of a provirus derived from an individual with tropical spastic paraparesis.

Microbial pathogenesis·1990
Same author

Spontaneous lymphocyte proliferation in symptom-free HTLV-I positive Jamaicans.

Lancet (London, England)·1989
Same author

Mechanisms in multiple sclerosis.

Nature·1985
Same author

Viral antibodies in twins with multiple sclerosis.

Neurology·1985

Related Experiment Video

Updated: Apr 22, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

15.9K

Altered immune function in demyelinative disease.

D McFarlin1, B Waksman2

  • 1Dale E. McFarlin is Chief, Neuroimmunology Branch, National Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, U.S.A.

Immunology Today
|October 8, 2014
PubMed
Summary
This summary is machine-generated.

Experimentally induced demyelination in mice can be autoimmune or viral. A workshop explored damaging mechanisms relevant to multiple sclerosis (MS) and human encephalomyelitis.

More Related Videos

Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis
09:01

Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis

Published on: November 17, 2020

6.2K
Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

1.4K

Related Experiment Videos

Last Updated: Apr 22, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

15.9K
Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis
09:01

Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis

Published on: November 17, 2020

6.2K
Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

1.4K

Area of Science:

  • Neuroscience
  • Immunology
  • Virology

Background:

  • Demyelination, a key feature of neurological diseases, can be triggered by autoimmune responses or viral infections in experimental models.
  • Understanding the mechanisms of demyelination is crucial for developing treatments for conditions like multiple sclerosis.

Purpose of the Study:

  • To discuss the damaging mechanisms involved in experimentally induced demyelination.
  • To explore the relevance of these mechanisms to human demyelinating diseases, including multiple sclerosis and human encephalomyelitis.

Main Methods:

  • Review of experimental mouse models with autoimmune-induced demyelination.
  • Analysis of experimental mouse models with virally induced demyelination.
  • Discussion among invited experts at a Kroc Foundation workshop.

Main Results:

  • Identified shared and distinct damaging mechanisms in autoimmune versus viral demyelination models.
  • Highlighted the potential for cross-relevance of findings between animal models and human diseases.
  • Emphasized the need for further research into specific molecular and cellular pathways.

Conclusions:

  • Experimentally induced demyelination provides valuable insights into the pathogenesis of multiple sclerosis and human encephalomyelitis.
  • Further investigation into the complex interplay of immune and viral factors in demyelination is warranted.
  • Collaborative discussions are essential for advancing the understanding and treatment of demyelinating diseases.